Literature DB >> 29188502

Small Scale Production of Recombinant Adeno-Associated Viral Vectors for Gene Delivery to the Nervous System.

Joost Verhaagen1, Barbara Hobo2, Erich M E Ehlert2,3, Ruben Eggers2, Joanna A Korecka2,4, Stefan A Hoyng2,5, Callan L Attwell2, Alan R Harvey6,7, Matthew R J Mason2.   

Abstract

Adeno-associated viral vectors have numerous applications in neuroscience, including the study of gene function in health and disease, targeting of light-sensitive proteins to anatomically distinct sets of neurons to manipulate neuronal activity (optogenetics), and the delivery of fluorescent protein to study anatomical connectivity in the brain. Moreover several phase I/II clinical trials for gene therapy of eye and brain diseases with adeno-associated viral vectors have shown that these vectors are well tolerated by human patients. In this chapter we describe a detailed protocol for the small scale production of recombinant adeno-associated viral vectors. This protocol can be executed by investigators with experience in cell culture and molecular biological techniques in any well-equipped molecular neurobiology laboratory. With this protocol we typically obtain research batches of 100-200 μL that range in titer from 5 × 1012 to 2 × 1013 genomic copies/mL.

Entities:  

Keywords:  Adeno-associated viral vector; Amicon centrifugation device; Iodixanol; Production; Purification; Serotype

Mesh:

Year:  2018        PMID: 29188502     DOI: 10.1007/978-1-4939-7522-8_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  ORANGE: A CRISPR/Cas9-based genome editing toolbox for epitope tagging of endogenous proteins in neurons.

Authors:  Jelmer Willems; Arthur P H de Jong; Nicky Scheefhals; Eline Mertens; Lisa A E Catsburg; Rogier B Poorthuis; Fred de Winter; Joost Verhaagen; Frank J Meye; Harold D MacGillavry
Journal:  PLoS Biol       Date:  2020-04-10       Impact factor: 8.029

2.  Inhibition of Semaphorin3A Promotes Ocular Dominance Plasticity in the Adult Rat Visual Cortex.

Authors:  Elena Maria Boggio; Erich M Ehlert; Leonardo Lupori; Elizabeth B Moloney; Fred De Winter; Craig W Vander Kooi; Laura Baroncelli; Vasilis Mecollari; Bas Blits; James W Fawcett; Joost Verhaagen; Tommaso Pizzorusso
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

3.  CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer's disease.

Authors:  Simone M Crivelli; Qian Luo; Jo A A Stevens; Caterina Giovagnoni; Daan van Kruining; Gerard Bode; Sandra den Hoedt; Barbara Hobo; Anna-Lena Scheithauer; Jochen Walter; Monique T Mulder; Christopher Exley; Matthew Mold; Michelle M Mielke; Helga E De Vries; Kristiaan Wouters; Daniel L A van den Hove; Dusan Berkes; María Dolores Ledesma; Joost Verhaagen; Mario Losen; Erhard Bieberich; Pilar Martinez-Martinez
Journal:  Alzheimers Res Ther       Date:  2021-02-17       Impact factor: 6.982

4.  The Jun-dependent axon regeneration gene program: Jun promotes regeneration over plasticity.

Authors:  Matthew R J Mason; Susan van Erp; Kim Wolzak; Axel Behrens; Gennadij Raivich; Joost Verhaagen
Journal:  Hum Mol Genet       Date:  2022-04-22       Impact factor: 5.121

5.  Chondroitin 6-sulphate is required for neuroplasticity and memory in ageing.

Authors:  Sylvain Gigout; Angelo Molinaro; Sujeong Yang; Yuko Naito-Matsui; Sam Hilton; Simona Foscarin; Bart Nieuwenhuis; Chin Lik Tan; Joost Verhaagen; Tommaso Pizzorusso; Lisa M Saksida; Timothy M Bussey; Hiroshi Kitagawa; Jessica C F Kwok; James W Fawcett
Journal:  Mol Psychiatry       Date:  2021-07-16       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.